Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy | Zendy

Corrado Murtas | Zendy; Maurizio Bruschi | Zendy; Giovanni Candiano | Zendy; Gabriella Moroni | Zendy; Riccardo Magistroni | Zendy; Andrea Magnano | Zendy; Francesca Bruno | Zendy; Antonella Radice | Zendy; Luciana Furci | Zendy; Lucia Argentiero | Zendy; Maria Luisa Carnevali | Zendy; Piergiorgio Messa | Zendy; Francesco Scolari | Zendy; Renato Alberto Sinico | Zendy; Loreto Gesualdo | Zendy; Fernando C. Fervenza | Zendy; Landino Allegri | Zendy; Pietro Ravani | Zendy; Gian Marco Ghiggeri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy

Author(s) -

Corrado Murtas,

Maurizio Bruschi,

Giovanni Candiano,

Gabriella Moroni,

Riccardo Magistroni,

Andrea Magnano,

Francesca Bruno,

Antonella Radice,

Luciana Furci,

Lucia Argentiero,

Maria Luisa Carnevali,

Piergiorgio Messa,

Francesco Scolari,

Renato Alberto Sinico,

Loreto Gesualdo,

Fernando C. Fervenza,

Landino Allegri,

Pietro Ravani,

Gian Marco Ghiggeri

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02170312

Subject(s) - medicine , autoantibody , antibody , membranous nephropathy , isotype , proteinuria , immunology , immunoglobulin g , nephrology , nephropathy , endocrinology , kidney , diabetes mellitus , monoclonal antibody

The discovery of different podocyte autoantibodies in membranous nephropathy (MN) raises questions about their pathogenetic and clinical meaning. This study sought to define antibody isotypes and correlations; to compare levels in MN, other glomerulonephritides, and controls; and to determine their association with clinical outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research